# active_site_0026

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `active_site`  
**Author expected answer:** **C** — Position 131 (Charge relay system)

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MKFLCLHGAYGNIPAFRVQLGPMIDALEFDGSASFEFIQGRVSVVPPPGFESYFGPAPHYRFLKDRGEAEASAVEGIRVFPEAETPEDALRALMPRDDMEIGFADARGLALEQLYEALDADPEISGIIGYSEGASAAATLVYDEQERMRSEGYVPRIKAAIFFMGWPALTAENVPALSDEVENLLEVPSLHIVGANDPYKDGALALYNIFDDNMAVFFDSAGGHTIPRHGKLLQELVSAVKDLIADVPEDNSADLLAPAVTGKRLDSAVDIPNLSFLKNEDA

[Multiple Choices]
A. Position 1334 (Proton acceptor; for dehydratase activity)
B. Position 131 (Charge relay)
C. Position 131 (Charge relay system)
D. Position 1045 (Proton acceptor; for dehydratase activity)
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Enzyme Active Site Prediction, which is to identify the key amino acid residues that form the active site of an enzyme. The active site is the specific region on the enzyme where a substrate binds and the chemical reaction is catalyzed. Based on the full protein sequence provided, you must select the option that correctly lists the amino acid residues (by their type and position) that constitute the enzyme's catalytic center.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence exactly matches the UniProt entry annotating position 131 as an active site with the description “Charge relay system.” The annotation is supported by similarity transfer, not by direct experimental evidence in the supplied material.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> The sequence length rules out positions 1045 and 1334, but the sequence and choices provide no defensible way to identify position 131 as the annotated charge-relay active site.


**Missing item-specific fact**

> The protein-specific active-site annotation that position 131 participates in a charge-relay system.


**Reason**

> Identifying that annotation requires a protein-specific fact absent from the prompt; recognizing or retrieving the sequence’s database annotation would be lookup, not reasoning from the supplied information.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "C"
]
```

> B and C both specify position 131 and the same charge-relay role; “Charge relay” and “Charge relay system” do not meaningfully distinguish them.


### Important caveats

- The supporting annotation is transferred by similarity (ECO:0000250), so it should not be described as direct experimental confirmation for this sequence.
- The reviewer-only evidence confirms an exact sequence match; that identity and annotation were not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence length rules out positions 1045 and 1334, but the sequence and choices provide no defensible way to identify position 131 as the annotated charge-relay active site.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein-specific active-site annotation that position 131 participates in a charge-relay system.",
    "reason": "Identifying that annotation requires a protein-specific fact absent from the prompt; recognizing or retrieving the sequence’s database annotation would be lookup, not reasoning from the supplied information."
  },
  "case_id": "active_site_0026",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt entry annotating position 131 as an active site with the description “Charge relay system.” The annotation is supported by similarity transfer, not by direct experimental evidence in the supplied material."
  },
  "important_caveats": [
    "The supporting annotation is transferred by similarity (ECO:0000250), so it should not be described as direct experimental confirmation for this sequence.",
    "The reviewer-only evidence confirms an exact sequence match; that identity and annotation were not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "C"
    ],
    "reason": "B and C both specify position 131 and the same charge-relay role; “Charge relay” and “Charge relay system” do not meaningfully distinguish them."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "active_site_0026",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence exactly matches the UniProt entry annotating position 131 as an active site with the description “Charge relay system.” The annotation is supported by similarity transfer, not by direct experimental evidence in the supplied material.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "The sequence length rules out positions 1045 and 1334, but the sequence and choices provide no defensible way to identify position 131 as the annotated charge-relay active site.",
    "missing_item_specific_fact": "The protein-specific active-site annotation that position 131 participates in a charge-relay system.",
    "reason": "Identifying that annotation requires a protein-specific fact absent from the prompt; recognizing or retrieving the sequence’s database annotation would be lookup, not reasoning from the supplied information."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "C"],
    "reason": "B and C both specify position 131 and the same charge-relay role; “Charge relay” and “Charge relay system” do not meaningfully distinguish them."
  },
  "important_caveats": [
    "The supporting annotation is transferred by similarity (ECO:0000250), so it should not be described as direct experimental confirmation for this sequence.",
    "The reviewer-only evidence confirms an exact sequence match; that identity and annotation were not provided to the evaluated model."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt annotation for A0A385XI13 (Esterase 1, EST1, from Aureobasidium melanogenum) explicitly annotates an active site at position 131 with the description 'Charge relay system' (evidence C5, H3). The sequence is 282 residues long, making positions 1334 and 1045 impossible. Position 131 corresponds to a serine residue, consistent with the nucleophilic serine of a serine esterase. However, the annotation carries evidence code ECO:0000250 (inferred by similarity to P38777), meaning it is a computational/homology-based annotation, not direct experimental determination.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [H1](#evidence-h1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The protein is 282 amino acids long, so positions 1334 (A) and 1045 (D) are immediately impossible. The protein is annotated as an esterase (EC 3.1.2.-). Serine hydrolases/esterases use a Ser-His-Asp/Glu catalytic triad, commonly termed a 'charge relay system.' Counting the sequence reveals position 131 is a serine (S), consistent with the nucleophilic residue of a serine esterase. The standard enzymological term for the full triad mechanism is 'charge relay system' (the complete Ser-His-Asp network), whereas 'charge relay' alone is an incomplete shorthand.


**Missing item-specific fact**

> The distinction between B ('Charge relay') and C ('Charge relay system') is essentially a verbatim annotation-wording issue. Both describe the same catalytic mechanism. No biological property of the protein distinguishes these two phrasings; selecting C over B relies on matching the exact UniProt annotation string rather than on any functional or structural reasoning.


**Reason**

> The core task—identifying position 131 as the catalytic serine of an esterase and eliminating out-of-range positions—is achievable through general biological reasoning (sequence length check, esterase catalytic mechanism recognition, serine identification). However, the final B-vs-C discrimination is a trivial wording match to the UniProt annotation convention and does not require independent biological reasoning.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[
  "B",
  "C"
]
```

> Choices B and C describe the same active site (position 131) with semantically equivalent descriptions ('Charge relay' vs 'Charge relay system'). No biological property of the protein distinguishes these two phrasings. A model selecting B would be functionally correct in substance. The 'correct' answer depends on exact UniProt annotation wording rather than on a biologically meaningful distinction.


### Important caveats

- The active site annotation is computational (ECO:0000250, inferred by similarity to P38777), not experimentally validated for this specific protein.
- The B-vs-C distinction is a trivial wording issue; the benchmark treats 'Charge relay system' as uniquely correct over 'Charge relay,' which is an annotation-convention match rather than a biological fact.
- The sequence is 282 residues; positions 1334 and 1045 are clearly out of range, making A and D trivially eliminable.
- The UniProt entry was first released in 2025-02-05; the annotation history is short and the similarity-based evidence code means the active site assignment is transferred, not independently measured.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The protein is 282 amino acids long, so positions 1334 (A) and 1045 (D) are immediately impossible. The protein is annotated as an esterase (EC 3.1.2.-). Serine hydrolases/esterases use a Ser-His-Asp/Glu catalytic triad, commonly termed a 'charge relay system.' Counting the sequence reveals position 131 is a serine (S), consistent with the nucleophilic residue of a serine esterase. The standard enzymological term for the full triad mechanism is 'charge relay system' (the complete Ser-His-Asp network), whereas 'charge relay' alone is an incomplete shorthand.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The distinction between B ('Charge relay') and C ('Charge relay system') is essentially a verbatim annotation-wording issue. Both describe the same catalytic mechanism. No biological property of the protein distinguishes these two phrasings; selecting C over B relies on matching the exact UniProt annotation string rather than on any functional or structural reasoning.",
    "reason": "The core task—identifying position 131 as the catalytic serine of an esterase and eliminating out-of-range positions—is achievable through general biological reasoning (sequence length check, esterase catalytic mechanism recognition, serine identification). However, the final B-vs-C discrimination is a trivial wording match to the UniProt annotation convention and does not require independent biological reasoning."
  },
  "case_id": "active_site_0026",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "H1"
    ],
    "judgment": "supported",
    "reason": "The UniProt annotation for A0A385XI13 (Esterase 1, EST1, from Aureobasidium melanogenum) explicitly annotates an active site at position 131 with the description 'Charge relay system' (evidence C5, H3). The sequence is 282 residues long, making positions 1334 and 1045 impossible. Position 131 corresponds to a serine residue, consistent with the nucleophilic serine of a serine esterase. However, the annotation carries evidence code ECO:0000250 (inferred by similarity to P38777), meaning it is a computational/homology-based annotation, not direct experimental determination."
  },
  "important_caveats": [
    "The active site annotation is computational (ECO:0000250, inferred by similarity to P38777), not experimentally validated for this specific protein.",
    "The B-vs-C distinction is a trivial wording issue; the benchmark treats 'Charge relay system' as uniquely correct over 'Charge relay,' which is an annotation-convention match rather than a biological fact.",
    "The sequence is 282 residues; positions 1334 and 1045 are clearly out of range, making A and D trivially eliminable.",
    "The UniProt entry was first released in 2025-02-05; the annotation history is short and the similarity-based evidence code means the active site assignment is transferred, not independently measured."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [
      "B",
      "C"
    ],
    "reason": "Choices B and C describe the same active site (position 131) with semantically equivalent descriptions ('Charge relay' vs 'Charge relay system'). No biological property of the protein distinguishes these two phrasings. A model selecting B would be functionally correct in substance. The 'correct' answer depends on exact UniProt annotation wording rather than on a biologically meaningful distinction."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "active_site_0026",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt annotation for A0A385XI13 (Esterase 1, EST1, from Aureobasidium melanogenum) explicitly annotates an active site at position 131 with the description 'Charge relay system' (evidence C5, H3). The sequence is 282 residues long, making positions 1334 and 1045 impossible. Position 131 corresponds to a serine residue, consistent with the nucleophilic serine of a serine esterase. However, the annotation carries evidence code ECO:0000250 (inferred by similarity to P38777), meaning it is a computational/homology-based annotation, not direct experimental determination.",
    "evidence_ids": ["C5", "H3", "C4", "H1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The protein is 282 amino acids long, so positions 1334 (A) and 1045 (D) are immediately impossible. The protein is annotated as an esterase (EC 3.1.2.-). Serine hydrolases/esterases use a Ser-His-Asp/Glu catalytic triad, commonly termed a 'charge relay system.' Counting the sequence reveals position 131 is a serine (S), consistent with the nucleophilic residue of a serine esterase. The standard enzymological term for the full triad mechanism is 'charge relay system' (the complete Ser-His-Asp network), whereas 'charge relay' alone is an incomplete shorthand.",
    "missing_item_specific_fact": "The distinction between B ('Charge relay') and C ('Charge relay system') is essentially a verbatim annotation-wording issue. Both describe the same catalytic mechanism. No biological property of the protein distinguishes these two phrasings; selecting C over B relies on matching the exact UniProt annotation string rather than on any functional or structural reasoning.",
    "reason": "The core task—identifying position 131 as the catalytic serine of an esterase and eliminating out-of-range positions—is achievable through general biological reasoning (sequence length check, esterase catalytic mechanism recognition, serine identification). However, the final B-vs-C discrimination is a trivial wording match to the UniProt annotation convention and does not require independent biological reasoning."
  },
  "question_ambiguity": {
    "multiple_defensible_options": ["B", "C"],
    "reason": "Choices B and C describe the same active site (position 131) with semantically equivalent descriptions ('Charge relay' vs 'Charge relay system'). No biological property of the protein distinguishes these two phrasings. A model selecting B would be functionally correct in substance. The 'correct' answer depends on exact UniProt annotation wording rather than on a biologically meaningful distinction."
  },
  "important_caveats": [
    "The active site annotation is computational (ECO:0000250, inferred by similarity to P38777), not experimentally validated for this specific protein.",
    "The B-vs-C distinction is a trivial wording issue; the benchmark treats 'Charge relay system' as uniquely correct over 'Charge relay,' which is an annotation-convention match rather than a biological fact.",
    "The sequence is 282 residues; positions 1334 and 1045 are clearly out of range, making A and D trivially eliminable.",
    "The UniProt entry was first released in 2025-02-05; the annotation history is short and the similarity-based evidence code means the active site assignment is transferred, not independently measured."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `A0A385XI13` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 13. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A385XI13.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:45.462174+00:00.  

```json
{"alternativeNames":[{"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"32003433","source":"PubMed"}],"value":"Liamocins biosynthesis cluster protein EST1"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"32003433","source":"PubMed"}],"value":"3.1.2.-"}],"fullName":{"evidences":[{"evidenceCode":"ECO:0000303","id":"32003433","source":"PubMed"}],"value":"Esterase 1"},"shortNames":[{"evidences":[{"evidenceCode":"ECO:0000303","id":"32003433","source":"PubMed"}],"value":"EST1"}]}}
```

Source SHA-256: `0604cd5410cd5850ed1061ec3c5b369f42c7da183cd38472972d9c4ba536b805`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A385XI13.json)  
**Locator:** `/features/1`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-01T06:24:45.462174+00:00.  

```json
{"description":"Charge relay system","evidences":[{"evidenceCode":"ECO:0000250","id":"P38777","source":"UniProtKB"}],"location":{"end":{"modifier":"EXACT","value":131},"start":{"modifier":"EXACT","value":131}},"type":"Active site"}
```

Source SHA-256: `0604cd5410cd5850ed1061ec3c5b369f42c7da183cd38472972d9c4ba536b805`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A385XI13?format=txt&versions=13)  
**Locator:** `lines 1-14`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 13 / 1.  
**Retrieved:** 2026-11-01T06:27:29.350597+00:00.  

```text
ID   EST1_AURME              Reviewed;         282 AA.
AC   A0A385XI13;
DT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.
DT   05-DEC-2018, sequence version 1.
DT   28-JAN-2026, entry version 13.
DE   RecName: Full=Esterase 1 {ECO:0000303|PubMed:32003433};
DE            Short=EST1 {ECO:0000303|PubMed:32003433};
DE            EC=3.1.2.- {ECO:0000269|PubMed:32003433};
DE   AltName: Full=Liamocins biosynthesis cluster protein EST1 {ECO:0000303|PubMed:32003433};
GN   Name=EST1 {ECO:0000303|PubMed:32003433};
OS   Aureobasidium melanogenum (Aureobasidium pullulans var. melanogenum).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Dothideomycetes;
OC   Dothideomycetidae; Dothideales; Saccotheciaceae; Aureobasidium.
OX   NCBI_TaxID=46634;
```

Source SHA-256: `2adf58d8fd74514947bfa0569f28f495b9be466e1ab51987b05e8007a9a288ca`.

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A385XI13?format=txt&versions=13)  
**Locator:** `lines 106-108`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 13 / 1.  
**Retrieved:** 2026-11-01T06:27:29.350597+00:00.  

```text
FT   ACT_SITE        131
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:P38777"
```

Source SHA-256: `2adf58d8fd74514947bfa0569f28f495b9be466e1ab51987b05e8007a9a288ca`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/active_site.json), zero-based source row 26. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
